Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-11-11

Clinical Trial Update: A Crossover Safety Study of Ferumoxytol Versus Placebo [Phase 3]

View source ↗

Summary

Phase 3 crossover safety study comparing ferumoxytol to placebo in patients with anemia has completed. The report focuses on safety outcomes observed during the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FERUMOXYTOL (ferumoxytol)

Snippet

Sponsor: AMAG Pharmaceuticals, Inc. | Conditions: Anemia | Phase 3 | Status: COMPLETED